Sri Lanka, Oct. 19 -- Sri Lanka's first insulin manufacturing plant is expected to begin production in 2027, following the completion of construction and the necessary validation processes, Health and Mass Media Minister Dr. Nalinda Jayatissa said.

The facility, established by Premium International Injectable (Pvt) Ltd. at the Koggala Export Processing Zone in Galle, represents an investment of more than Rs. 3 billion.

The Minister made these remarks during a visit to the facility on October 17, noting that the project marked a significant step towards reducing the country's dependence on imported medicines and strengthening domestic pharmaceutical manufacturing.

The company plans to initially manufacture insulin before expanding prod...